Shuai Xia

机构：Yichun University, National Clinical Research Center for Digestive Diseases · ORCID：0000-0002-1390-5533

发表论文 23 篇 · 总被引 237 次 · h-index 7

代表论文

• Discovery of Hydrocarbon-Stapled Short α-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors (2018 · Journal of Medicinal Chemistry · 被引 61)
• De Novo Design of α-Helical Lipopeptides Targeting Viral Fusion Proteins: A Promising Strategy for Relatively Broad-Spectrum Antiviral Drug Discovery (2018 · Journal of Medicinal Chemistry · 被引 56)
• Expanding the DNA-encoded library toolbox: identifying small molecules targeting RNA (2022 · Nucleic Acids Research · 被引 38)
• Recompensation in treatment-naïve HBV-related decompensated cirrhosis: a 5-year multi-center observational study comparing patients with ascites and bleeding (2023 · Hepatology International · 被引 21)
• Supercoiling Structure-Based Design of a Trimeric Coiled-Coil Peptide with High Potency against HIV-1 and Human β-Coronavirus Infection (2021 · Journal of Medicinal Chemistry · 被引 17)
• Small molecule tyrosine kinase inhibitors approved for systemic therapy of advanced hepatocellular carcinoma: recent advances and future perspectives (2024 · Discover Oncology · 被引 10)